These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 25111376)

  • 1. Down-modulation of Bcl-2 sensitizes PTEN-mutated prostate cancer cells to starvation and taxanes.
    Calastretti A; Gatti G; Quaresmini C; Bevilacqua A
    Prostate; 2014 Oct; 74(14):1411-22. PubMed ID: 25111376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preferential chemosensitization of PTEN-mutated prostate cells by silencing the Akt kinase.
    Priulla M; Calastretti A; Bruno P; Azzariti A; Paradiso A; Canti G; Nicolin A
    Prostate; 2007 May; 67(7):782-9. PubMed ID: 17373720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential sensitivity of human glioblastoma LN18 (PTEN-positive) and A172 (PTEN-negative) cells to Taxol for apoptosis.
    Zhang R; Banik NL; Ray SK
    Brain Res; 2008 Nov; 1239():216-25. PubMed ID: 18804099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of Wnt signaling downregulates Akt activity and induces chemosensitivity in PTEN-mutated prostate cancer cells.
    Ohigashi T; Mizuno R; Nakashima J; Marumo K; Murai M
    Prostate; 2005 Jan; 62(1):61-8. PubMed ID: 15389810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PTEN induces chemosensitivity in PTEN-mutated prostate cancer cells by suppression of Bcl-2 expression.
    Huang H; Cheville JC; Pan Y; Roche PC; Schmidt LJ; Tindall DJ
    J Biol Chem; 2001 Oct; 276(42):38830-6. PubMed ID: 11495901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-like growth factor-type 1 receptor inhibitor NVP-AEW541 enhances radiosensitivity of PTEN wild-type but not PTEN-deficient human prostate cancer cells.
    Isebaert SF; Swinnen JV; McBride WH; Haustermans KM
    Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):239-47. PubMed ID: 21816290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Silencing of the IGF1R gene enhances sensitivity to DNA-damaging agents in both PTEN wild-type and mutant human prostate cancer.
    Rochester MA; Riedemann J; Hellawell GO; Brewster SF; Macaulay VM
    Cancer Gene Ther; 2005 Jan; 12(1):90-100. PubMed ID: 15499378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effect of anti-apoptotic genes Bcl-xL and c-FLIP on sensitivity of MCF-7 breast cancer cells to paclitaxel and docetaxel.
    Wang Z; Goulet R; Stanton KJ; Sadaria M; Nakshatri H
    Anticancer Res; 2005; 25(3c):2367-79. PubMed ID: 16080463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance.
    McCubrey JA; Steelman LS; Abrams SL; Lee JT; Chang F; Bertrand FE; Navolanic PM; Terrian DM; Franklin RA; D'Assoro AB; Salisbury JL; Mazzarino MC; Stivala F; Libra M
    Adv Enzyme Regul; 2006; 46():249-79. PubMed ID: 16854453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PI3K/Akt signaling regulates p27(kip1) expression via Skp2 in PC3 and DU145 prostate cancer cells, but is not a major factor in p27(kip1) regulation in LNCaP and PC346 cells.
    van Duijn PW; Trapman J
    Prostate; 2006 May; 66(7):749-60. PubMed ID: 16425184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PTEN expression controls cellular response to cetuximab by mediating PI3K/AKT and RAS/RAF/MAPK downstream signaling in KRAS wild-type, hormone refractory prostate cancer cells.
    Bouali S; Chrétien AS; Ramacci C; Rouyer M; Becuwe P; Merlin JL
    Oncol Rep; 2009 Mar; 21(3):731-5. PubMed ID: 19212633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blocked autophagy using lysosomotropic agents sensitizes resistant prostate tumor cells to the novel Akt inhibitor AZD5363.
    Lamoureux F; Thomas C; Crafter C; Kumano M; Zhang F; Davies BR; Gleave ME; Zoubeidi A
    Clin Cancer Res; 2013 Feb; 19(4):833-44. PubMed ID: 23258740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular aspects of gefitinib antiproliferative and pro-apoptotic effects in PTEN-positive and PTEN-negative prostate cancer cell lines.
    Festuccia C; Muzi P; Millimaggi D; Biordi L; Gravina GL; Speca S; Angelucci A; Dolo V; Vicentini C; Bologna M
    Endocr Relat Cancer; 2005 Dec; 12(4):983-98. PubMed ID: 16322337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha-tomatine synergises with paclitaxel to enhance apoptosis of androgen-independent human prostate cancer PC-3 cells in vitro and in vivo.
    Lee ST; Wong PF; Hooper JD; Mustafa MR
    Phytomedicine; 2013 Nov; 20(14):1297-305. PubMed ID: 23920276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of PKCδ Induces Prostate Cancer Resistance to Paclitaxel through Activation of Wnt/β-Catenin Pathway and Mcl-1 Accumulation.
    Flores ML; Castilla C; Gasca J; Medina R; Pérez-Valderrama B; Romero F; Japón MA; Sáez C
    Mol Cancer Ther; 2016 Jul; 15(7):1713-25. PubMed ID: 27196755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthetic Lethality in PTEN-Mutant Prostate Cancer Is Induced by Combinatorial PI3K/Akt and BCL-XL Inhibition.
    Ren W; Joshi R; Mathew P
    Mol Cancer Res; 2016 Dec; 14(12):1176-1181. PubMed ID: 27590631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SRJ23, a new semisynthetic andrographolide derivative: in vitro growth inhibition and mechanisms of cell cycle arrest and apoptosis in prostate cancer cells.
    Wong HC; Wong CC; Sagineedu SR; Loke SC; Lajis NH; Stanslas J
    Cell Biol Toxicol; 2014 Oct; 30(5):269-88. PubMed ID: 25070834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combining paclitaxel with ABT-263 has a synergistic effect on paclitaxel resistant prostate cancer cells.
    Wang C; Huang SB; Yang MC; Lin YT; Chu IH; Shen YN; Chiu YH; Hung SH; Kang L; Hong YR; Chen CH
    PLoS One; 2015; 10(3):e0120913. PubMed ID: 25811469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IMP3 accelerates the progression of prostate cancer through inhibiting PTEN expression in a SMURF1-dependent way.
    Zhang X; Wang D; Liu B; Jin X; Wang X; Pan J; Tu W; Shao Y
    J Exp Clin Cancer Res; 2020 Sep; 39(1):190. PubMed ID: 32938489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenoviral-mediated PTEN transgene expression sensitizes Bcl-2-expressing prostate cancer cells to radiation.
    Rosser CJ; Tanaka M; Pisters LL; Tanaka N; Levy LB; Hoover DC; Grossman HB; McDonnell TJ; Kuban DA; Meyn RE
    Cancer Gene Ther; 2004 Apr; 11(4):273-9. PubMed ID: 14765130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.